search
Back to results

Feasibility & Acceptability of a Virtual Sister Circle Intervention for Black Women With Depressive Symptoms

Primary Purpose

Depressive Symptoms, Depression

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Sister Circle protocol
Sponsored by
Kia Skrine Jeffers, PhD, RN, PHN
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Depressive Symptoms focused on measuring Sister Circle, Black Women

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Identify as Black or African American
  • Identify as female
  • Age 40 years and older
  • Community-dwelling
  • Self-report of experiencing depressive symptoms
  • Ability to commit to the 8-week intervention
  • Access to Zoom
  • Speak and read English

Exclusion Criteria:

  • Have a diagnosis of bipolar, but is not taking medication for the condition
  • Experiencing psychosis

Sites / Locations

  • University of California, Los Angeles

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Group 1 Intervention, Weeks 1-8

Group 2 Intervention, Weeks 9-16

Arm Description

During Weeks 1-8, Group 1 receives the Intervention and Group 2 receives no treatment.

During Weeks 9-16, Group 2 receives the Intervention and Group 1 receives no treatment.

Outcomes

Primary Outcome Measures

Recruitment, completion, and retention rates of participants
80 percent recruitment, 80 percent completion, and 75 percent retention
Assess Acceptability according to the Theoretical Framework of Acceptability
Qualitative assessment of Acceptability. The interview guide will be organized according to the constructs of the Theoretical Framework of Acceptability. Methodological conventions of qualitative description will be used to analyze the data.

Secondary Outcome Measures

Changes in Perceived Stress Scale (PSS) from baseline at 8 weeks and 16 weeks
Exploratory description of effect sizes
Changes in Positive and Negative Affect Schedule (PANAS) Scale from baseline at 8 weeks and 16 weeks
Exploratory description of effect sizes
Changes in Acceptance and Action Questionnaire II (AAQ-II) from baseline at 8 weeks and 16 weeks
Exploratory description of effect sizes

Full Information

First Posted
March 29, 2021
Last Updated
October 17, 2023
Sponsor
Kia Skrine Jeffers, PhD, RN, PHN
search

1. Study Identification

Unique Protocol Identification Number
NCT04837573
Brief Title
Feasibility & Acceptability of a Virtual Sister Circle Intervention for Black Women With Depressive Symptoms
Official Title
Evaluating the Feasibility and Acceptability of a Therapeutically-Grounded Virtual Sister Circle Intervention for Black Women With Depressive Symptoms
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Completed
Study Start Date
September 14, 2022 (Actual)
Primary Completion Date
April 2, 2023 (Actual)
Study Completion Date
April 2, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Kia Skrine Jeffers, PhD, RN, PHN

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate the feasibility and acceptability of a protocol for middle- and older-aged Black women with depressive symptoms.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depressive Symptoms, Depression
Keywords
Sister Circle, Black Women

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group 1 Intervention, Weeks 1-8
Arm Type
Experimental
Arm Description
During Weeks 1-8, Group 1 receives the Intervention and Group 2 receives no treatment.
Arm Title
Group 2 Intervention, Weeks 9-16
Arm Type
Active Comparator
Arm Description
During Weeks 9-16, Group 2 receives the Intervention and Group 1 receives no treatment.
Intervention Type
Behavioral
Intervention Name(s)
Sister Circle protocol
Intervention Description
The intervention is an 8-week, therapeutically-informed protocol.
Primary Outcome Measure Information:
Title
Recruitment, completion, and retention rates of participants
Description
80 percent recruitment, 80 percent completion, and 75 percent retention
Time Frame
16 weeks
Title
Assess Acceptability according to the Theoretical Framework of Acceptability
Description
Qualitative assessment of Acceptability. The interview guide will be organized according to the constructs of the Theoretical Framework of Acceptability. Methodological conventions of qualitative description will be used to analyze the data.
Time Frame
16 weeks
Secondary Outcome Measure Information:
Title
Changes in Perceived Stress Scale (PSS) from baseline at 8 weeks and 16 weeks
Description
Exploratory description of effect sizes
Time Frame
baseline, 8 weeks, 16 weeks
Title
Changes in Positive and Negative Affect Schedule (PANAS) Scale from baseline at 8 weeks and 16 weeks
Description
Exploratory description of effect sizes
Time Frame
baseline, 8 weeks, 16 weeks
Title
Changes in Acceptance and Action Questionnaire II (AAQ-II) from baseline at 8 weeks and 16 weeks
Description
Exploratory description of effect sizes
Time Frame
baseline, 8 weeks, 16 weeks

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Self-identified females
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Identify as Black or African American Identify as female Age 40 years and older Community-dwelling Self-report of experiencing depressive symptoms Ability to commit to the 8-week intervention Access to Zoom Speak and read English Exclusion Criteria: Have a diagnosis of bipolar, but is not taking medication for the condition Experiencing psychosis
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kia Skrine Jeffers, PhD, RN, PHN
Organizational Affiliation
University of California, Los Angeles
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California, Los Angeles
City
Los Angeles
State/Province
California
ZIP/Postal Code
90095
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Feasibility & Acceptability of a Virtual Sister Circle Intervention for Black Women With Depressive Symptoms

We'll reach out to this number within 24 hrs